Luan T - Search Results

1

Value of Quantitative SPECT/CT Lymphoscintigraphy in Improving Sentinel Lymph Node Biopsy in Breast Cancer.

Luan T, Li Y, Wu Q, Wang Y, Huo Z, Wang X, Xing L, Sun X. Luan T, et al. Breast J. 2022 Mar 28;2022:6483318. doi: 10.1155/2022/6483318. eCollection 2022. Breast J. 2022. PMID: 35711901 Free PMC article.

2

A Radiomics Nomogram for Preoperative Prediction of Clinical Occult Lymph Node Metastasis in cT1-2N0M0 Solid Lung Adenocarcinoma.

Zhang R, Zhang R, Luan T, Liu B, Zhang Y, Xu Y, Sun X, Xing L. Zhang R, et al. Among authors: luan t. Cancer Manag Res. 2021 Oct 28;13:8157-8167. doi: 10.2147/CMAR.S330824. eCollection 2021. Cancer Manag Res. 2021. PMID: 34737644 Free PMC article.

3

Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.

Li X, Fu S, Huang Y, Luan T, Wang H, Wang J. Li X, et al. Among authors: luan t. BMC Cancer. 2021 Nov 24;21(1):1267. doi: 10.1186/s12885-021-09006-w. BMC Cancer. 2021. PMID: 34819038 Free PMC article.

4

LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.

Huang L, Luan T, Chen Y, Bao X, Huang Y, Fu S, Wang H, Wang J. Huang L, et al. Among authors: luan t. J Cancer. 2018 Feb 28;9(6):1017-1024. doi: 10.7150/jca.23087. eCollection 2018. J Cancer. 2018. PMID: 29581781 Free PMC article.

5

Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.

Huang Y, Wang H, Fu S, Luan T, Zuo Y, Li N, Ding M, Chen Y, Wang J. Huang Y, et al. Among authors: luan t. Eur J Cancer Prev. 2020 Jul;29(4):329-337. doi: 10.1097/CEJ.0000000000000551. Eur J Cancer Prev. 2020. PMID: 31577563

6

Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer.

Wang Z, Shang Y, Luan T, Duan Y, Wang J, Wang H, Hao J. Wang Z, et al. Among authors: luan t. Cancer Imaging. 2020 Apr 6;20(1):26. doi: 10.1186/s40644-020-00304-3. Cancer Imaging. 2020. PMID: 32252816 Free PMC article.

7

Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA.

He Z, Gu J, Luan T, Li H, Li C, Chen Z, Luo E, Wang J, Huang Y, Ding M. He Z, et al. Among authors: luan t. Front Immunol. 2022 Sep 20;13:973974. doi: 10.3389/fimmu.2022.973974. eCollection 2022. Front Immunol. 2022. PMID: 36211333 Free PMC article.

8

MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.

Luan T, Fu S, Huang L, Zuo Y, Ding M, Li N, Chen J, Wang H, Wang J. Luan T, et al. Exp Cell Res. 2018 Dec 15;373(1-2):188-197. doi: 10.1016/j.yexcr.2018.10.013. Epub 2018 Oct 25. Exp Cell Res. 2018. PMID: 30463687

9

miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2.

Fu S, Luan T, Jiang C, Huang Y, Li N, Wang H, Wang J. Fu S, et al. Among authors: luan t. Gene. 2019 Jun 15;701:23-31. doi: 10.1016/j.gene.2019.02.083. Epub 2019 Mar 19. Gene. 2019. PMID: 30898713

10

Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.

Gu J, He Z, Huang Y, Luan T, Chen Z, Wang J, Ding M. Gu J, et al. Among authors: luan t. Dis Markers. 2022 May 23;2022:5204831. doi: 10.1155/2022/5204831. eCollection 2022. Dis Markers. 2022. PMID: 35664432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters